Curated Wealth Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
363,902
+361,785
+17,090% +$77.8M 0.21% 88
2026
Q1
$460K Sell
2,117
-50
-2% -$11.1K 0.06% 117
2025
Q4
$495K Buy
2,167
+582
+37% +$133K 0.05% 120
2025
Q3
$367K Sell
1,585
-320
-17% -$65.2K 0.04% 113
2025
Q2
$354K Sell
1,905
-32
-2% -$5.95K 0.04% 115
2025
Q1
$406K Buy
1,937
+28
+1% +$5.44K 0.05% 102
2024
Q4
$339K Sell
1,909
-107
-5% -$19.7K 0.04% 108
2024
Q3
$398K Sell
2,016
-11
-0.5% -$2.05K 0.05% 96
2024
Q2
$348K Buy
+2,027
New +$336K 0.05% 96
2024
Q1
Sell
-2,149
Closed -$370K 140
2023
Q4
$333K Sell
2,149
-103
-5% -$15K 0.05% 105
2023
Q3
$336K Sell
2,252
-325
-13% -$47.7K 0.06% 100
2023
Q2
$347K Sell
2,577
-238
-8% -$34.9K 0.07% 94
2023
Q1
$449K Sell
2,815
-124
-4% -$19K 0.1% 74
2022
Q4
$475K Buy
2,939
+75
+3% +$11.5K 0.12% 67
2022
Q3
$382K Sell
2,864
-44
-2% -$6.31K 0.11% 80
2022
Q2
$444K Sell
2,908
-501
-15% -$76.6K 0.13% 73
2022
Q1
$461K Hold
3,409
0.16% 78
2021
Q4
$461K Buy
3,409
+39
+1% +$4.61K 0.15% 81
2021
Q3
$363K Sell
3,370
-136
-4% -$15.5K 0.2% 97
2021
Q2
$394K Buy
3,506
+929
+36% +$105K 0.21% 89
2021
Q1
$279K Buy
+2,577
New +$276K 0.17% 112

Other funds holding ABBV

Curated Wealth Partners's ABBV Position: Q2 2026 in Review

Curated Wealth Partners increased its AbbVie (ABBV) stake by 17,090% in Q2 2026, buying an estimated $77.8M and bringing the position to 363,902 shares worth $1.59M. The position accounts for 0.21% of the portfolio, ranked #88.

Curated Wealth Partners first reported a position in ABBV in Q1 2021 and has held it in 21 quarters since. 1,620 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Curated Wealth Partners held 363,902 shares of AbbVie worth $1.59M as of Q2 2026.
  • Curated Wealth Partners bought 361,785 AbbVie shares in Q2 2026, an estimated $77.8M.
  • AbbVie made up 0.21% of Curated Wealth Partners's portfolio in Q2 2026, its #88 holding.
  • Curated Wealth Partners first reported a position in AbbVie in Q1 2021 and has held it in 21 quarters since.
  • 1,620 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.